You are on page 1of 1

316 A novel cMET inhibitor, MK8033, potentiates the activity of carboplatin/paclitaxel in ovarian cancer cell lines D. Marchion, I.

. Ramirez-Diaz, N. Bou Zgheib, Y. Xiong, X. Stickles, P. Judson Lancaster, J. Gonzalez Bosquet, R. Wenham, S. Apte, J. Lancaster H. Lee Moffitt Cancer Center, Tampa, FL 334 The HIV protease inhibitor ritonavir induces cell cycle arrest and apoptosis in the A2780 ovarian cancer cell line in vitro and in vivo B. Winterhoff1, A. Teoman1, L. Freyer1, A. Von Bismarck1, S. Dowdy1, B. Schmalfeldt2, S. Kumar1, V. Shridhar1 1 Mayo Clinic, Rochester, MN, 2Technical University of Munich, Munich, Germany 325 Chemokine receptors enhance T-cell vaccine cell homing to ovarian cancer E. Zsiros1, P. Duttagupta2, T. Garrabrant2, B. Levine2, J. Tanyi2, L. Kandalaft2, G. Coukos2 1 University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania Medical Center, Philadelphia, PA
N. Howlader, A. M. Noone, M. Krapcho, et al., SEER Cancer Statistics Review, National Cancer Institute, Bethesda, Md, USA, 1975/2009, http://seer.cancer.gov/csr/1975_2009_pops09/. T. Kaku, S. Ogawa, Y. Kawano et al., Histological classification of ovarian cancer, Medical Electron Microscopy, vol. 36, no. 1, pp. 917, 2003. View at Publisher View at Google Scholar View at Scopus (Fuertes et al., 2002). (Korolkavas, 1988).